RootPath Raises $7 Million As Investor Interest In Cell Therapy Soars
Immuno-oncology startup, RootPath has raised $7 million in a seed funding round for its next generation T-Cell therapy. The funding round was led by…
Exploring News, Ideas, and Perspectives
Immuno-oncology startup, RootPath has raised $7 million in a seed funding round for its next generation T-Cell therapy. The funding round was led by…